Researchers uncover the genetic diversity of relapse in T-cell Acute Lymphoblastic Leukaemia June 02, 2025 Researchers uncover the genetic diversity of relapse in T-cell Acute Lymphoblastic Leukaemia
Dr Pablo Menéndez receives the FERO-Aladina Paediatric Cancer Award May 29, 2025 Dr Pablo Menéndez receives the FERO-Aladina Paediatric Cancer Award
Dual action immunotherapy in CAR-T cells improves control of B-ALL progression May 27, 2025 Dual action immunotherapy in CAR-T cells improves control of B-ALL progression
Dr Manel Esteller receives the Jaume Aiguader i Miró Award from the Academy of Medical and Health Sciences May 22, 2025 Dr Manel Esteller receives the Jaume Aiguader i Miró Award from the Academy of Medical and Health Sciences
A step closer to the confident production of blood stem cells for regenerative medicine May 16, 2025 A step closer to the confident production of blood stem cells for regenerative medicine
Epigenetics predicts the aggressiveness of Burkitt Lymphoma, a common paediatric tumour in developing countries May 14, 2025 Epigenetics predicts the aggressiveness of Burkitt Lymphoma, a common paediatric tumour in developing countries
Latest research on Plasmablastic Lymphoma discovers a new therapeutic opportunity May 12, 2025 Latest research on Plasmablastic Lymphoma discovers a new therapeutic opportunity
CarrerasLeaders opens its fourth call for postdoctoral researchers in blood cancers May 07, 2025 CarrerasLeaders opens its fourth call for postdoctoral researchers in blood cancers
A common alteration in acute myeloid leukaemia helps cancer cells survive and holds the potential for new therapies May 05, 2025 A common alteration in acute myeloid leukaemia helps cancer cells survive and holds the potential for new therapies
Verónica Rodilla and José L. Sardina receive the Research Consolidation grant from the Spanish State Research Agency April 30, 2025 Verónica Rodilla and José L. Sardina receive the Research Consolidation grant from the Spanish State Research Agency
New CAR-T Therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma April 29, 2025 New CAR-T Therapy achieves positive results in a high proportion of patients with a refractory type of lymphoma
